Разрешен к применению с 1995 года.
Видео о
Купить в
COVID-19 
По алфавиту
- A
- B
- C
- D
- E
- F
- G
- H
- I
- J
- K
- L
- M
- N
- O
- P
- Q
- R
- S
- T
- V
- W
- X
- Y
- Z
- І
- А
- Б
- В
- Г
- Д
- Е
- Ж
- З
- И
- К
- Л
- М
- Н
- О
- П
- Р
- С
- Т
- У
- Ф
- Х
- Ц
- Ч
- Ш
- Щ
- Э
- Ю
- Я
- Весь список
Warning: mb_strpos(): Empty delimiter in /var/www/u1363561/data/www/biotech.spb.ru/wp-content/plugins/code-snippets/php/snippet-ops.php(581) : eval()’d code(4) : eval()’d code on line 13
E Baumgarten, H Schmid, U Pohl, J Brzoska, C Linderkamp, W Siegert, G Henze
Low-dose natural interleukin-2 and recombinant interferon-gamma following autologous bone marrow grafts in pediatric patients with high-risk acute leukemiaLeukemia. 1994 May;8(5):850-5.
E Huland, A Burger, J Fleischer, P Fornara, E Hatzmann, A Heidenreich, H Heinzer, H Heynemann, L Hoffmann, R Hofmann, H Huland, I Kämpfer, M Kindler, H Kirchner, G Mehlhorn, T H Moniak, U Rebmann, J Roigas, T H Schneider, D Schnorr, H J Schmitz, R Wenisch
Efficacy and safety of inhaled recombinant interleukin-2 in high-risk renal cell cancer patients compared with systemic interleukin-2: an outcome studyFolia Biol (Praha). 2003;49(5):183-90.
E Huland, H Heinzer, H Huland
A comparison of systemic versus inhaled recombinant IL-2 administration for the treatment of metastatic renal cell carcinomaFolia Biol (Praha). 2000;46(6):241-50.
E Huland, H Heinzer, H Huland
Treatment of pulmonary metastatic renal-cell carcinoma in 116 patients using inhaled interleukin-2 (IL-2)Anticancer Res. Jul-Aug 1999;19(4A):2679-83.
E Huland, H Heinzer, H Huland, R Yung
Overview of interleukin-2 inhalation therapyCancer J Sci Am. 2000 Feb;6 Suppl 1:S104-12.
E Huland, H Heinzer, T S Mir, H Huland
Inhaled interleukin-2 therapy in pulmonary metastatic renal cell carcinoma: six years of experienceCancer J Sci Am. 1997 Dec;3 Suppl 1:S98-105.
E L Hänninen, A Körfer, M Hadam, C Schneekloth, I Dallmann, T Menzel, H Kirchner, H Poliwoda, J Atzpodien
Biological monitoring of low-dose interleukin 2 in humans: soluble interleukin 2 receptors, cytokines, and cell surface phenotypesCancer Res. 1991 Dec 1;51(23 Pt 1):6312-6.
E Lopez Hänninen, H Kirchner, J Atzpodien
Interleukin-2 based home therapy of metastatic renal cell carcinoma: risks and benefits in 215 consecutive single institution patientsJ Urol. 1996 Jan;155(1):19-25.
Eberlein TJ, Schoof DD.
The role of interleukin-2 in cancer immunotherapy.Compr Ther. 1991 Jan;17(1):49-56. PMID: 2001612.
Ee W Su, Caitlin J Moore, Samantha Suriano, Christopher Bryce Johnson, Neizel Songalia, Alicia Patterson, Daniel J Neitzke, Kristina Andrijauskaite, Elizabeth Garrett-Mayer, Shikhar Mehrotra, Chrystal M Paulos, Andrew L Doedens, Ananda W Goldrath, Zihai L
IL-2Rα mediates temporal regulation of IL-2 signaling and enhances immunotherapySci Transl Med. 2015 Oct 28;7(311):311ra170.
Elaine T Lam, Michael K K Wong, Neeraj Agarwal et al.
Retrospective Analysis of the Safety and Efficacy of High-dose Interleukin-2 After Prior Tyrosine Kinase Inhibitor Therapy in Patients With Advanced Renal Cell Carcinoma.Journal of immunotherapy (Hagerstown, Md.: 1997) . – 2014. — July 37(7).
Elizabeth I Buchbinder, Janice P Dutcher, Gregory A Daniels, Brendan D Curti, Sapna P Patel, Shernan G Holtan, Gerald P Miletello, Mayer N Fishman, Rene Gonzalez, Joseph I Clark, John M Richart, Christopher D Lao, Scott S Tykodi, Ann W Silk, David F McDer
Therapy with high-dose Interleukin-2 (HD IL-2) in metastatic melanoma and renal cell carcinoma following PD1 or PDL1 inhibitionJ Immunother Cancer. 2019 Feb 18;7(1):49.
Emilio Esteban-González, Joaquín Carballido, Víctor Navas, Zoila Torregrosa, Antonio Muñoz, Melchor Alvarez de Mon, PortugueseSpanish Inhaled IL-2 Group
Retrospective review in patients with pulmonary metastases of renal cell carcinoma receiving inhaled recombinant interleukin-2Anticancer Drugs. 2007 Mar;18(3):291-6.
Enhancement of in vitro interleukin-2 production in normal subjects following a single spinal manipulative treatment
Enhancement of in vitro interleukin-2 production in normal subjects following a single spinal manipulative treatment.Chiropr Osteopat. 2008 May 28;16:5. doi: 10.1186/1746-1340-16-5. PMID: 18507834; PMCID: PMC2423359.
Eric J Hsu, Xuezhi Cao, Benjamin Moon, Joonbeom Bae, Zhichen Sun, Zhida Liu, Yang-Xin Fu 
PDF
Nat Commun. 2021 May 13;12(1):2768.
Ettinghausen SE, Rosenberg SA.
Immunotherapy of murine sarcomas using lymphokine activated killer cells: optimization of the schedule and route of administration of recombinant interleukin-2.Cancer Res. 1986 Jun;46(6):2784-92. PMID: 3486038.
В соответствии с п. 1 ст. 64 Федерального закона от 12.04.2010 № 61-ФЗ "Об обращении лекарственных средств" лекарственные препараты, находящиеся в обращении на территории Российской Федерации, подлежат мониторингу безопасности в целях выявления возможных негативных последствий их применения, предупреждения пациентов и их защиты от применения таких препаратов.